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Wound healingMigration of cells in the ocular surface underpins physiological wound healing as well as many human
diseases. Transglutaminase (TG)-2 is a multifunctional cross-linking enzyme involved in the migration of
skin ﬁbroblasts and wound healing, however, its functional role in epithelial migration has not been evaluat-
ed. This study investigated the importance of TG-2 in a murine corneal wound healing model as well as the
mechanistic role of TG-2 in the regulation of related biological processes such as cell adhesion and migration
of cultured human corneal epithelial (HCE-T) cells. Corneal wound closure was delayed in homozygous TG-2
deleted mice compared to wild type mice. HCE-T cells that were knocked-down for TG-2 expression through
stable expression of a short-hairpin (sh) RNA targeting TG-2, were delayed in closure of scratch wounds (48
compared to 12 h in control cells expressing scrambled shRNA). TG-2 knockdown did not inﬂuence epithelial
cell cycle progression or proliferation, rather, it led to reduced epithelial cell adhesion, spreading and velocity
of migration. At the molecular level, TG-2 knockdown reduced phosphorylation of β-3 integrin at Tyr747,
paxillin at Ser178, vinculin at Tyr822 and focal adhesion kinase at Tyr925 simultaneous with reduced activa-
tion of Rac and CDC42. Phosphorylation of paxillin at Ser178A has been shown to be indispensable for the
migration of corneal epithelial cells (Kimura et al., 2008) [18]. TG-2 dependent β-3 integrin activation,
serine-phosphorylation of paxillin, and Rac and CDC42 activation may thus play a key functional role in
enhancing corneal epithelial cell adhesion and migration during wound healing.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Transglutaminase (TG)-2 [1] is a multi-functional cross-linking pro-
tein that is ubiquitously expressed [2,3]. It is able to covalently
cross-link peptide substrates and also serve as a G protein [2]. Recently
cell surface TG-2, localized at the basal and apical surfaces of cells and
cell–cell contacts [4], has been implicated in cell–matrix interactions
[5], which may affect cell adhesion and migration properties [6,7].
β-Integrins 1 and 3, vital for cell–matrix interactions, are colocalized
with TG-2 and mediate outside-in signaling of cell surface TG-2 [8]. Al-
though connective tissue structures (anchoring ﬁbrils, microﬁbrils and
collagen ﬁbrils) that are linked to epithelial cells via hemidesmosomesnter, 11 Third Hospital Avenue,
+65 63224599.
).
l rights reserved.are crosslinking substrates of TG-2 [9], cell surface functions of TG-2 are
not dependent on transamidase activity [4,10]. Thus, TG-2 can inﬂu-
ence cell adhesion and migration through the other types of protein–
protein interactions apart from catalyzing cross-linking of matrix
substrates.
TG-2 is expressed in various ocular structures [11]. Previous work
shows that TG-2 affects conjunctival inﬂammation and eosinophilic
inﬁltration in a guinea pig model [12], it is involved in pterygium, a
common ocular surface disease with ﬁbrovascular proliferation and
matrix anomalies [13], and it is up-regulated in the healing process
in a rat corneal abrasion model [14].
The roles of TG-2 in various wound healing related processes are
diverse [15] and include the regulation of matrix stability and scarring,
platelet aggregation and angiogenesis during the various stages of
wound healing. The role of TG-2 in wound healing in the ocular surface
has not been evaluated. Wound healing in cornea will reduce transpar-
ency and affect visual function; hence it deserves to be evaluated as a
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cell-adhesion complex is vital for adhesion and migration of corneal
epithelial cells [16]. Although TG-2 is known to signal through β-1
integrin to p190RhoGAP via phosphorylation of src kinase upon ﬁbro-
blast adhesion [17], it is not known how TG-2 affects other proteins
in the cell-adhesion complex.
In this study, we evaluated the role of TG-2 in a murine corneal
wound healing model, as well as the mechanistic role of TG-2 in the
regulation of related biological processes such as cell adhesion and
migration of cultured human corneal epithelial cells.
2. Materials and methods
2.1. Mouse model of corneal wound healing
Mice were handled according to guidelines in the Association for
Research in Vision and Ophthalmology Statement for the Use of
Animals in Ophthalmic and Vision Research and protocols approved
by the Institutional Animal Care and Use Committee of SingHealth. Het-
erozygous TG-2-deleted mice (Tgm2tm1.1Rmgr) originally on a mixed
C57BL/6J–129S1/SvImJ strain background were established as previ-
ously described [18] and backcrossed more than 12 generations to
C57BL/6J to generate congenic heterozygote (TG-2+/−) mice that
share >99.95% genomic homogeneity with C57BL/6J. Congenic
C57BL/6J TG-2+/− mice were bred to generate homozygous
(TG-2−/−) and wild type (TG-2+/+) littermate founders. Mice were
anesthetized by intraperitoneal injection of ketamine hydrochloride
(2 mg/g body weight; Parnell Laboratories, Mascot, NSW, Australia)
and xylazine (0.4 mg/g body weight; Troy Laboratories, Smithﬁeld,
NSW, Australia); depth of anesthesia was monitored by limb with-
drawal using toe pinching. The central cornea was marked by a
trephine 2 mm in diameter and the epithelium was peeled off using
forceps under a dissecting microscope. Wound closure was assessed
by ﬂuorescein staining (5 s, sterile 1% Minims ﬂuorescein sodium solu-
tion (Bausch & Lomb, Rochester, NY, USA; diluted 1:4 in sterile saline))
followed by sterile saline rinsing and digital camera photography in co-
balt blue light with ultraviolet light ﬁlters. Wound area was deter-
mined (Kodak Molecular Imaging Software, Carestream Health Inc.,
Rochester, New York) and expressed as a percentage of total wounded
corneal area.
2.2. Cell culture
Human SV-40 immortalized corneal epithelial cell line HCE-T (RCB
1384, Riken Cell Bank, Ibaraki, Japan) provided courtesy of Kaoru
Araki-Sasaki (Kinki Central Hospital, Hyogo, Japan) [19] was used at
passages 88 to 98. All cell lines were cultured in DMEM-F12/5% FBS
(Invitrogen, Grand Island, NY, USA) in a humidiﬁed 5% CO2 incubator
at 37 °C with fresh medium replaced every 2 days.
2.3. Stably transfected cell lines
HCE-T cells stably transduced with shRNA targeting TG-2 (referred
to as shRNA TG-2) and HCE-T cells stably transduced with non-speciﬁc
scrambled shRNA (referred to as scrambled shRNA) were described
previously [20].
2.4. Measurement of cell area
shRNA TG-2 or scrambled shRNA stably-transfected HCE-T cells
were cultured on uncoated or ﬁbronectin-coated dishes with serum-
supplemented medium until 80% conﬂuency, incubated in serum-free
medium overnight, then seeded into uncoated or ﬁbronectin pre-
coated 8-well chamber slides (BD Biosciences, MA, USA) overnight.
Using ImageJ software (National Institute of Health, USA), cell bound-
aries including cytoplasmic protrusions of non-overlapping cells wereoutlined manually on captured images (20× magniﬁcation, Axioplan
2 ﬂuorescence microscope, Carl Zeiss, Oberkochen, Germany) and cell
area was measured. Nuclear boundaries of the same cells were drawn
to calculate nuclei areas.
2.5. Scratch wound assay
shRNA TG-2 or scrambled shRNA stably-transfected HCE-T cells
were seeded in duplicate in uncoated or ﬁbronectin-coated 6-well
tissue culture plates and grown for 24 h to produce a conﬂuent
monolayer of cells. Nine straight scratches were made with a 1 mL
blue pipette tip. Re-epithelialization of the denuded area was deter-
mined (ImageJ software) from images captured at ﬁxed positions
every 2 h for 14 h.
2.6. Two-D cell migration assay
shRNA TG-2 or scrambled shRNA stably-transfected HCE-T cells
were seeded in a 6 mm culture glass cylinder (Bioptechs, PA, USA)
ﬁlled with serum-supplemented medium. After overnight incubation,
the culture cylinder was removed and cell migration was recorded
every 10 min for 100 frames (around 16 h). Cell centroids were com-
puted after manually outlining cells using ImageJ software.
2.7. Cell trypsinization assays
Cells were washed with phosphate buffered saline (PBS, 1st base,
Singapore), incubated with PBS-diluted 0.005% Trypsin-EDTA (Sigma,
Saint Louis, MO, USA) at 37 °C, 5% CO2 for 1 h and photographed peri-
odically without mechanical perturbation.
2.8. Cell impedance studies
Cell impedance properties were monitored using the Xcelligence
system (Roche Applied Science, Basel, Switzerland), which dynamically
monitors cell events in real-time. The presence of cells on top of elec-
trodes affects the local ionic environment at the electrode/solution
interface, leading to an increase in electrode impedance, which is
displayed as cell index (CI) values [21].
2.9. Cell proliferation assays
Cell proliferation/viability was assessed by 3-(4,5-imethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) colorimetric assay using the CellTiter 96® Aqueous One Solution
Cell Proliferation assay (Promega, Madison, WI, USA). Cell proliferation
was also analyzed 3 to 8 h after the scratch test by Ki-67 staining of cells
ﬁxed as for immunoﬂuorescent staining below. Positively-stained cells
(green) within contiguous cells of a conﬂuent area were counted 3
times in each cell type.
2.10. Immunoﬂuorescence staining
This was performed as previously described [22]. Brieﬂy, cultured
cells were ﬁxed (4% paraformaldehyde, room temperature, 15 min),
blocked for non-speciﬁc binding (30 min), appropriate primary anti-
body, then secondary antibody was added. Table 1 lists primary and
secondary antibodies used.
For mouse tissue, 10 μm cryostat sections were placed on poly-L-
lysine-coated slides, ﬁxed (4% paraformaldehyde, 20 min), rinsed
(PBS), permeabilized (30 min, 0.15% Triton X-100; Sigma), blocked
(30 min, 4% bovine serum albumin BSA; Sigma), incubated with
primary antibody (mouse phospho Ser178 paxillin, 30 min, room
temperature in moist chamber), rinsed (PBS) and incubated with
FITC conjugated secondary antibody (20 min, room temperature in
moist chamber). After rinsing (PBS), samples were embedded in
Table 1
List of antibodies used.
Antigen Antibody (catalog number) Dilution Species Source
Transglutaminase 2 ab421 1: 50 (IFa) Rabbit Abcam
Anti-(Ki) 67 18-0191Z 1:40 (IFa) Rabbit Invitrogen
Phospho-β3 integrin (Tyr747)b ab38460 1: 400 (western)
1: 50 (IFa)
Rabbit Abcam
Phospho-β1 integrin (S785) ab5185 1: 200 (western) Rabbit Abcam
Phospho-vinculin integrin (Tyr 822) V4889 1: 1000 (western)
1: 50 (IFa)
Rabbit Sigma
Phospho-Paxillin (S178) A300-100A 1: 1000 (western)
1: 100 (IFa)
Rabbit Bethyl Laboratories
Phospho-FAK (Tyr576) #07-157 1: 150 (western) Rabbit Millipore
Phospho-FAK (Tyr925) #3284 1: 500 (western) Rabbit Cell Signaling
Integrin β3 ab34409 1: 400 (western) Mouse Abcam
Integrin β1 MAB1965 1: 200 (western) Mouse Millipore
Vinculin clone hVIN-1 V4505 1: 400 (western) Mouse Sigma
Paxillin P1093 1: 500 (western) Mouse Sigma
FAK 610087 1: 200 (western) Mouse BD Biosciences
Talin T3287 1: 500 Mouse Sigma
β-Actin ab8227 1: 1000 Rabbit Abcam
Anti-mouse IgG (whole molecule) FITC F2012 1: 800 Goat Sigma
Anti-rabbit Alexa Fluor 488 A11070 1: 800 Goat Invitrogen
Anti-mouse HRP A9044 1: 5000 Goat Sigma
Anti-rabbit HRP A0545 1: 5000 Goat Sigma
a Immunoﬂuorescence staining.
b Although called integrin beta 3-phospho-Y773 antibody in manufacturer's catalog, it refers to the same tyrosine residue because amino acid counting starts from N terminus of
propeptide.
1306 L. Tong et al. / Biochimica et Biophysica Acta 1833 (2013) 1304–1315UltraCruzTM mounting medium with DAPI (Santa Cruz, California,
USA). Tissue sections not incubated with primary antibody were
used as negative controls.
2.11. Western blot
This was performed as previously described [20]. Scrambled shRNA
(8 × 105) and shRNA TG-2 (1 × 106) stably-transfected HCE-T cells
cultured in serum-supplemented medium until 60–70% conﬂuency
were passaged and seeded to 60–70% conﬂuency overnight in serum-
free medium in a new culture vessel. After aspiration of culture
medium, cells were washed three times in PBS, placed on ice and fresh-
ly prepared RIPA lysis buffer (50 mM Tris–HCL, pH 7.4, 1% NP40, 0.5%
sodium deoxycholate, 0.1% SDS, 150 mM sodium chloride, 2 mM
EDTA, and 50 mM sodium ﬂuoride) containing a cocktail of protease
and phosphatase inhibitors (Sigma-Aldrich and Roche) was added.
Cells were gently scraped and collected. Protein concentration was
measured using the micro-BCA method. Sample buffer containing
β-mercaptoethanol was added to 70 μg of protein for each sample
and heated to 95 °C for 5 min. Subsequent SDS-PAGE and transfer to
immunoblots were performed as previously described [20]. Table 1
lists primary and secondary antibodies used.
2.12. Cell cycle analysis
4 × 105 cells were cultured for 2 days. Non-adherent and trypsin-
ized cells were pelleted, resuspended in 500 μL PBS, transferred drop
by drop to 4.5 mL of chilled ethanol while gently vortexing, incubated
in ethanol (overnight, 4 °C), pelleted, resuspended in PBS (5 mL, room
temperature, 1 min), pelleted by centrifugation and resuspended in
GUAVA cell cycle reagent (Millipore, MA, USA) at a concentration
recommended by the manufacturer, followed by 30 min room temper-
ature incubation before analysis by mini-ﬂow cytometry (GUAVA,
Millipore). Data were analyzed by ExpressPro software.
2.13. Rho (RhoA, Cdc42 and Rac) protein activation assays
Small G-protein activity (G-LISA Assays, Cytoskeleton, Denver,
USA) was measured in stably-transfected HCE-T cells expressingshRNA TG-2 or scrambled shRNA that were cultured until 50%
conﬂuency in 5% FBS medium. Serum in the medium was used as
recommended by the manufacturer (Cytoskeleton) as one of the
known Rho activators to stimulate Rho protein activity in the cultured
cells.2.14. Statistical analysis
For continuous variables, all results shown are means ± SD.
Statistical differences for cell areas were determined by ANOVA with
post-hoc comparisons where the ANOVA is signiﬁcant. The general
linear model (GLM) procedure was used (SPSS, Inc.) for the evaluation
of velocity of cell migration and gapwidth in in vitro scratch assays. The
post hoc test option in the GLM procedure was used to evaluate for
signiﬁcant differences between the 4 conditions (cells with scrambled
shRNA and shRNA targeting TG2, either with or without ﬁbronectin),
p values adjusted for multiple comparisons were evaluated for statisti-
cal signiﬁcance. For categorical variables, proportions (e.g. proportions
of positively-labeled Ki-67 cells) were compared using the Chi square
test, with p ≤ 0.05 being considered signiﬁcant.3. Results
A uniform area of the corneal surface was abraded in wild type
(TG-2+/+) and homozygous TG-2 deleted (TG-2−/−) mice. Although
the time taken to repair the corneal epithelium varied depending on
wound depth and the way mechanical abrasion was performed,
ﬂuorescein staining of the cornea denuded of epithelium indicated
corneal wound closure was consistently delayed in TG-2−/− mice
compared to TG-2+/+ (Fig. 1A). Epithelial healing was completed
after 7 days in TG-2−/− compared to 4 days in TG-2+/+ (Fig. 1B)
with statistically signiﬁcant differences (p b 0.05) in residual epithe-
lial wound area from day 3 onwards. Immunoﬂuorescence staining
detected TG-2 in corneal epithelial layers and basement membrane
of TG-2+/+ mice but not in TG-2−/− mice (Fig. 1C). During the
healing process, it was observed that the new corneal epithelial cell
sheet in TG-2−/− mice was very friable and less adherent to the cor-
neal bed than in TG-2+/+ mice.
Fig. 1. Deletion of TG-2 from corneal epithelial layers and the basement membrane results in delayed corneal wound closure in homozygous transglutaminase (TG)-2 deleted
(TG-2−/−) mice relative to wild type control (TG-2+/+) mice. (A) Representative microscopy images of murine cornea following the removal of corneal epithelium from TG-2+/+
and TG-2−/− mice and topical ﬂuorescein staining of the epithelial defect (green). Scale bar = 100 μm. (B) Percentage of wound defect remaining (vertical axis) over time
(horizontal axis) in TG-2+/+ and TG-2−/− mice, n = 5 for each genotype from 3 independent experiments. *: p b 0.05. (C) Representative immunoﬂuorescence staining of central
unwounded TG-2+/+ and TG-2−/− mouse corneas with primary antibody against TG-2 and FITC conjugated secondary antibody (green) and with DAPI nuclear counterstaining (blue).
Scale bar = 50 μm.
1307L. Tong et al. / Biochimica et Biophysica Acta 1833 (2013) 1304–1315Due to the prohibitively high cost of primarymurine corneal epithe-
lial cell culturemedium the high volume of cells required for various as-
says, batch to batch variability of phenotype of primary cells upon
passaging, as well as the translational medicine implications of usinghuman cells, we investigated this further in vitro using immortalized
human corneal epithelial (HCE-T) cells stably transfected with shRNA
against TG-2 or with scrambled shRNA. The speciﬁcity of the shRNA
against TG-2 was conﬁrmed by us previously by showing that TG-2
1308 L. Tong et al. / Biochimica et Biophysica Acta 1833 (2013) 1304–1315transcript and protein are greatly reduced in HCE-T cells by this shRNA
[20], as is cell surface TG-2 expression (Supplementary File 1), and that
the functional effect of this reduction can be overcome by selectively
over-expressing wild type TG-2 [20]. In a scratch test assay, although
cell density was similar (p > 0.05, data not shown), shRNA TG-
2-expressing cells displayed delayed closure of a uniformwidth scratch
wound, with closure not evident until 48 h compared to 12 h in scram-
bled shRNA-expressing cells (Fig. 2A). This phenomenon was indepen-
dent of ﬁbronectin pre-coating of the culture vessel (Fig. 2A). The
difference in width of the residual wound between the two stably
transfected cell lines was statistically signiﬁcant (p b 0.05) from 6 h
after scratching (Fig. 2B). Upon general linear model (GLM) analysisFig. 2. Knockdown of TG-2 in corneal epithelial cells results in delayed closure of a scratch wou
after a single uniform width scratch wound of conﬂuent HCE-T cells stably transfected with a
uncoated or ﬁbronectin-coated surfaces. Scale bar = 50 μm. (B) Graph showing the percenta
dent experiments. *: p b 0.05.(2–14 h after scratching) the ‘within subject’ effect (time) was signiﬁ-
cant (p b 0.001) and the TG-2 status and ﬁbronectin coating were
signiﬁcant ‘between subject’ effects (p b 0.001). On post-hoc testing,
control cells grown on ﬁbronectin closed the wound signiﬁcantly faster
than shRNA TG-2-expressing cells on ﬁbronectin (p = 0.001) or shRNA
TG-2-expressing cells on uncoated plates (p = 0.005). Control cells cul-
tured on uncoated plates closed the wound faster than shRNA
TG-2-expressing cells on uncoated plates (p = 0.004) or shRNA
TG-2-expressing cells on ﬁbronectin-coated plates (p = 0.001). There
was no signiﬁcant difference in wound width between shRNA
TG-2-expressing cells cultured on plates with or without ﬁbronectin
(p = 0.885).nd. (A) Representative phase contrast microscopy images taken at various time intervals
scrambled shRNA (control) or a TG-2-targeting shRNA (shRNA TG-2), seeded on either
ge width of wound remaining (vertical axis) over time (horizontal axis), n = 6 indepen-
Fig. 3. Knockdown of TG-2 in corneal epithelial cells results in decreased velocity of cell migration. (A) Representative phase contrast microscopy images taken immediately after
the commencement of cell migration in HCE-T cells stably transfected with scrambled shRNA (control) or shRNA targeting TG-2 (shRNA TG-2), seeded on uncoated plates. This is a
non-traumatic cell migration assay (see ‘Materials and methods’). Scale bar = 50 μm. (B) Cell migration depicted as line plot of centroid positions of 50 randomly selected contig-
uous cells at the advancing edge, tracked every 10 min over 16 h by live cell time-lapse microscopy. Initial cell positions were normalized to plot origin. A representative experi-
ment from 3 independent experiments is shown.
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wound closure reﬂected a lower migration speed of shRNA TG-2-
expressing cells. On uncoated plates, scrambled shRNA-expressing
cells had signiﬁcantly higher velocity of movement (average speed of
0.42 ± 0.051 μm/min) compared to shRNA TG-2-expressing cells
(0.31 ± 0.033 μm/min; p b 0.0001; Fig. 3 and Supplementary File 2),
the difference in migration speed between scrambled shRNA- and
shRNA TG2-expressing cells being 0.42–0.31 or 0.11 μm/min. On
ﬁbronectin-coated plates, the difference in migration speed between
scrambled shRNA- and shRNA TG2-expressing cells was 0.66–0.54 or
0.12 μm/min (data not shown, lower magniﬁcation images shown in
Supplementary File 3). Upon GLM analysis with cell velocity at each
time interval (10 min segments repeated 99 times) as the dependent
variable, the ‘between subject’ factors (ﬁbronectin status and TG-2 sta-
tus) were signiﬁcant (p = 0.001). The time effect is signiﬁcant
(p b 0.001) and probably reﬂects increased velocity in the ﬁrst 25
time points (ﬁrst 4 h) (Supplementary File 4). On post hoc testing,
control cells migrated faster on ﬁbronectin than the other 3 conditions
(all p b 0.001); control cells on uncoated plates migrated signiﬁcantly
faster than shRNA TG-2-expressing cells on uncoated plates (p b 0.001),and shRNA TG-2-expressing cells on ﬁbronectin migrated faster than on
uncoated plates (p b 0.001). Therewas no difference in velocity between
control cells on uncoated plates and shRNA TG-2-expressing cells on
ﬁbronectin-coated plates (p = 1.0). There was also a tendency for cells
that expressed shRNA against TG-2 to be less adherent to the underlying
culture vessel, appearing as a loose sheet folding back on itself at themar-
gin of advancing cells.
One to six hours after seeding on uncoated plates, cells expressing
shRNA against TG-2 were signiﬁcantly reduced in cell impedance,
which measures cell properties such as cell number or adhesion/
area (Fig. 4A), relative to cells expressing scrambled shRNA (TG-2 sta-
tus p b 0.001). Each of the parameters potentially contributing to the
reduced cell impedance of shRNA TG-2-expressing cells was then
analyzed separately. Firstly, MTS assay of cell proliferation in pre-
conﬂuent monolayers seeded on uncoated plates (Fig. 4B) and steady
state cell cycle progression (Fig. 4C) indicated no difference in prolif-
eration rates. Consistent with these ﬁndings, 6 h after a scratch
wound the proportion of proliferating (Ki-67 positive) cells was low
(presumably still due to the effects of contact inhibition prior to
scratching) and was not signiﬁcantly different (p = 0.59) between
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and cells expressing shRNA against TG-2 [14/581 (95%CI: 0.0136–
0.0415)] (Fig. 4D). When individual single cells near the scratch
wound were tracked over 24 h, 1–2/50 cells divided. Secondly,
using time-lapse photography, the rate of cell detachment from
uncoated plates after trypsinization (Fig. 4E and Supplementary File
5) was greater in cells expressing shRNA against TG-2 than in cells ex-
pressing scrambled shRNA. We acknowledge that this result may not
be robust in the absence of a directional shearing force. Lastly, the
mean area of individual phalloidin-stained cells measured 24 h after
attachment on ﬁbronectin-coated plates was 555 ± 161 μm2 for
cells expressing shRNA against TG-2 compared to 682 ± 218 μm2
for cells expressing scrambled shRNA (p b 0.001). Interestingly,
there was no difference in cell area on uncoated plates (Fig. 4F), nor
was there a difference in nuclei area between groups (p > 0.05
ANOVA in Fig. 4F). Together, these ﬁndings indicate that the delayed
scratch wound closure rate of cells expressing shRNA TG-2, relative to
scrambled RNA, may be attributable to differential cell adhesion,
spreading and/or migration, but not proliferation.
Adhesion and directional migration of epithelial cells during
wound healing involve integrin activation, which mediates actinFig. 4. Knockdown of TG-2 in corneal epithelial cells results in decreased cell impedance due
liferation. (A) HCE-T cells stably transfected with scrambled shRNA (control) or shRNA tar
triplicate on uncoated plates and monitored non-invasively for cell impedance (cell index)
uncoated plates. Cell proliferation (y-axis) was measured at A490. (C) Cell cycle analysis
cells in G0/G1, S, and G2/M phases by mini-ﬂow cytometry. (D) Representative microscop
a single uniform width scratch wound of conﬂuent control or shRNA TG-2 cells, seeded on
time-lapse microscopy images of control and shRNA TG-2 cells on uncoated dishes after the
after 50 min for control, when all cells had detached. Detached cells are rounded and clumpe
ed for 24 h on ﬁbronectin-coated (+) or uncoated (−) plates. More than 500 attached cellstress ﬁber aggregation and formation of adhesion complexes in the
leading edge. To investigate the actin cytoskeleton of epithelial cells
expressing scrambled shRNA or shRNA against TG-2, ﬁlamentous
(F)-actin was ﬂuorescently stained using phalloidin, 3 h (Fig. 5) and
6 h (data not shown) after the scratch wound. At both time points,
cells expressing scrambled shRNA showed strong condensation of
F-actin around the cortex of advancing cells as well as over cell–cell
junctions, with most cells forming lamellipodia in the direction of
cell movement. In cells expressing shRNA against TG-2, however,
the pattern of F-actin was more disrupted at both time points, with
the detachment of individual cells at the advancing edge, and exten-
sion of lamellipodia not just towards the direction of the wound but
also at right angles to this (arrow in Fig. 5). This suggests that some
cells may have detached due to defective adhesion between the cell
and underlying substrate.
Next we investigated the role of TG-2 in phosphorylation of
integrins and various components of focal adhesion complexes in ep-
ithelial cells expressing scrambled shRNA or shRNA against TG-2,
plated in serum-free medium overnight to 60–70% conﬂuency on
uncoated plates (Fig. 6A–F). These experiments were repeated with
cells seeded on ﬁbronectin-coated plates for 5 h and similar resultsto decreased strength of adhesion and decreased cell spreading, with no effect on pro-
geting TG-2 (shRNA TG-2) were seeded (5 × 103 cells/200 mL DMEM-F12/5% FBS) in
over time. (B) MTS cell proliferation assay of control and shRNA TG-2 cells seeded on
of control or shRNA TG-2 cells using propidium iodide to measure the percentage of
y images of Ki-67 staining (green) to monitor cell proliferation (red arrows) 6 h after
uncoated plates. Blue, DAPI-stained cell nuclei. Scale bar = 50 μm. (E) Representative
addition of diluted trypsin. Imaging was discontinued after 25 min for shRNA TG-2 or
d together. (F) Cell (top) and nuclei (bottom) area of control or shRNA TG-2 cells seed-
s were selected over 3 independent experiments.*: p b 0.001.
Fig. 4 (continued).
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ylation of β-1 integrin (a known component of the early cell–matrix
adhesion complex) at Ser785 was not affected by the TG-2 status of
the cells. Similar results were obtained for cells grown on
ﬁbronectin-coated plates (data not shown). Although β-3 integrin
(another component of the adhesion complex) has been reported to
be absent from corneal epithelial cells [23], we were able to detect
β-3 integrin by Western blot in these cells (Fig. 6B) as well as in cul-
tured primary corneal epithelial cells grown from cadaveric limbal
explant tissue (Supplementary File 7A). In a separate GeneChip
study, we also found β-3 integrin transcripts in our corneal epithelial
cell line as well as in primary cultured corneal epithelial cells (Supple-
mentary File 7B). Moreover, phosphorylation of β-3 integrin at
Tyr747 was reduced in cells expressing shRNA against TG-2
compared to cells expressing scrambled shRNA (Fig. 6B). Reduced
phosphorylation was also observed for paxillin (another early adhe-
sion complex component) at Ser178 (Fig. 6C), vinculin (a component
of the late adhesion complex) at Tyr822 (Fig. 6D) and focal adhesion
kinase (FAK) at Tyr925, but not at Tyr576 (Fig. 6E) in cells expressing
shRNA against TG-2, relative to control cells expressing scrambled
shRNA. Because we observed less cell spreading (Fig. 4F) on
ﬁbronectin-coated, but not uncoated, plates in cells expressing
shRNA TG-2 relative to control shRNA, we compared the phosphory-
lation level of one of these components (paxillin phosphorylation atSer178) in cells plated in serum-free medium overnight on uncoated
versus ﬁbronectin-coated plates, and found similar levels of decreased
paxillin phosphorylation in cells expressing shRNA TG-2 relative to
control shRNA (data not shown). Consistent with these results, fol-
lowing the abrasion of the corneal surface of TG-2+/+ and TG-2−/−
mice, less phosphorylated paxillin was observed at the advancing
edge of corneal epithelium after 4 h and in repaired epithelium
after 120 h in TG-2−/− mice relative to TG-2+/+ mice (Fig. 6G).
Since nascent adhesion formation near the leading edge of
lamellipodia involves the activation of small GTPases, Rac and
CDC42, we investigated the level of activation of these proteins in
subconﬂuent cultures. Activation of RhoA was not affected by TG-2
status, whereas activation of Rac and CDC42 was reduced in cells ex-
pressing shRNA against TG-2 compared to cells expressing scrambled
shRNA (Fig. 6H).
4. Discussion
Using both an in vivomouse model of corneal abrasion (Fig. 1) and
a scratch wound of human corneal epithelial cells in vitro (Fig. 2) we
show for the ﬁrst time that corneal epithelial wound healing is
enhanced by TG-2. TG-2 does not inﬂuence epithelial cell cycle pro-
gression or proliferation (Fig. 4B–D), rather, TG-2 enhances epithelial
cell adhesion, spreading (Fig. 4E–F) and velocity of migration
Fig. 5. Knockdown of TG-2 in corneal epithelial cells results in actin cytoskeleton changes. Representative ﬂuorescence staining, using FITC-conjugated phalloidin (green), of an
in-vitro scratch wound 3 h post wounding of cultured HCE-T cells stably transfected with scrambled shRNA (control) or shRNA targeting TG-2 (shRNA TG-2) seeded on uncoated
plates. Nuclei were counterstained with DAPI (blue). White arrows indicate the direction of lamellipodia at the leading edge. Scale bar = 50 μm.
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leading edge of cytoplasmic processes, are critical to cell movement
[24], the observed effect on epithelial cell migration of TG-2 reduction
or absence likely reﬂects defective adhesion. This role of TG-2 is con-
sistent with previous work describing cell surface TG-2 involvement
in migration and/or adhesion of monocyte [8], retinal pigment epi-
thelial cell [25], endothelial [26], osteoblast [27], breast cancer [28]
and metastatic melanoma [29] cells. Interestingly, cell spreading
area of corneal epithelial cells expressing shRNA against TG-2 was
signiﬁcantly reduced when plated on Fn-coated plates, but was
comparable to control cells expressing scrambled shRNA when plated
on uncoated plates. A similar observation has been noted in human
endothelial cells stably transfected with antisense TG-2 cDNA [26].
Enhanced cell spreading on ﬁbronectin-coated relative to uncoated
plates is likely mediated through the direct interaction of TG-2 with
ﬁbronectin [30] in complex with integrins [5].
Although it is accepted that corneal epithelium containsβ-1 but lacks
β-3 integrin [23], we provide evidence using a well-characterized
antibody against β-3 integrin and phosphoTyr747 of β-3 integrin, that
β-3 integrin is indeed present in, and is activated in a TG-2-dependent
manner upon the adhesion of, the cultured corneal epithelial cell line,
HCE-T (Fig. 6). In addition, we found expression of β-3 integrin tran-
script and protein in primary human corneal epithelial cells cultured
from cadaveric limbal explants, as well as in the corneal epithelial cell
line HCE-T (Supplementary File 7).Fig. 6. Deletion or knockdown of TG-2 in corneal epithelial cells results in reduced phosphoryla
of GTPases, Rac and CDC42. (A–F) RepresentativeWestern blots of total cell lysates (50 μg) from
(shRNA TG-2) thatwere seeded in serum-starved conditions to 70% conﬂuency on uncoated pla
at Ser785 (pS785 β-1 integrin) and total β-1 integrin, (B) β-3 integrin phosphorylated at Tyr
(pS178 paxillin) and total paxillin, (D) vinculin phosphorylated at Tyr822 (pTyr822 vinculin
FAK) or Tyr576 (pTyr576 FAK) and total FAK, and (bottom panel) β-actin as loading control. (
dependent experiments. Anti-phospho-speciﬁc epitope intensities were normalized to anti-to
and expressed as fold change in the intensity of control cells. *p b 0.05 using the Mann Whit
from TG-2+/+ and TG-2−/− mice 4 h (top row) and 120 h (bottom row) post-wounding, s
FITC-conjugated secondary antibody (green). Nuclei were counterstained with DAPI (blue). R
margin of prominent staining of phosphorylated paxillin. Scale bar = 50 μm. (H) Activity assa
cells, cultured to 50% conﬂuency on uncoated plates, were assayed in G-LISA assays according
periments). *: p b 0.05.Phosphorylation of the tail of β-3 integrin at Tyr747 plays impor-
tant roles in both inside-out and outside-in signaling [31] and recruit-
ment of signaling components [32] during cell adhesion on tissue
culture plastic or matrix components [33]. Consistent with this
matrix-independent activation of β-3 integrin, cells expressing shRNA
against TG-2 were observed to have reduced phosphorylation of focal
adhesion complex protein paxillin at Ser178, relative to cells express-
ing scrambled shRNA, on uncoated or ﬁbronectin-coated plates
(Fig. 6C, data not shown). Given mutation of Ser178 of paxillin to Ala
inhibits the migration of the same line of human corneal epithelial
cells as we used in our study [16] and, moreover, that less Ser178-
phosphorylated paxillin was also observed at the delayed advancing
edge of corneal epithelium in TG-2−/− than in TG-2+/+mice following
the abrasion of the corneal surface (Fig. 6G), our study strongly sug-
gests that the mechanism by which TG-2 mediates corneal epithelial
wound closure involves serine phosphorylation of paxillin (Fig. 7).
Phosphorylation of vinculin at Tyr822 and of FAK at Tyr925, but not
Tyr576, was also TG-2-dependent (Fig. 6D, E). Of the three tyrosine res-
idues in FAK that have been studied in the context of strain-induced
epithelial cell migration, only phosphorylation of Tyr925 is required
for downstream signaling through the PI3K/Akt axis independent of
Src activation but dependent on Rac1 activation [34]. Rac and CDC42
are active in actin polymerization in the leading edge of moving cells
[35], and their inhibition leads to the disruption of lamellipodia
and ﬁlopodia formation [36,37]. Consistent with TG-2-dependenttion of a number of components of focal adhesion complexes as well as reduced activation
HCE-T cells stably transfected with scrambled shRNA (control) or shRNA targeting TG-2
tes, probedwith primary antibodies against (top panels) (A) β-1 integrin phosphorylated
747 (pTyr747 β-3 integrin) and total β-3 integrin, (C) paxillin phosphorylated at Ser178
) and total vinculin (E) focal adhesion kinase (FAK) phosphorylated at Tyr925 (pTyr925
F) Bar chart showing the normalization of densitometry of Western blots from 3 to 5 in-
tal intensities of the respective adhesion proteins (total integrin, paxillin, vinculin, FAK)
ney U test (G) Representative immunoﬂuorescence images of fresh frozen mouse cornea
tained with primary antibodies against paxillin phosphorylated at Ser178, followed by
ed arrows indicate the advancing edge of corneal epithelium, white arrows indicate the
ys for Rac (left), CDC42 (middle) and RhoA (right). Lysates from shRNA TG-2 and control
to manufacturer's instructions and absorbance read at 490 nm (n = 3 independent ex-
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Fig. 7. Schematic showing possible sites of TG2 involvement in human corneal epithelial cell adhesion and migration. FAK: focal adhesion kinase.
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against TG-2 we observed the disruption of the actin cytoskeleton in
cells at the edge of the scratch wound (Fig. 5) and reduced activation
of small GTPases, Rac and CDC42 (Fig. 6H), relative to cells expressing
scrambled shRNA. It is thus tempting to speculate that TG-2 enhances
corneal epithelial cell adhesion and migration through a pathway in-
volving β-3 integrin activation and serine-phosphorylation of paxillin
simultaneous with Rac and CDC42 activation.
Of interest, cell surface TG-2 has been shown to promote the activa-
tion of RhoA, upon nascent adhesion of ﬁbroblasts, via β-1 integrin
clustering and down-regulation of the Src-p190RhoGAP signaling path-
way [17]. Our current report has not extended to the study of cluster-
ing of adhesion molecules. This will be evaluated in future studies.
We were not able to study the effect of over-expressing TG-2 in
corneal epithelial cells because this intervention induced a signiﬁcant
amount of cell apoptosis and made it difﬁcult to achieve conﬂuence
for scratch test assays (data not shown). We were also unable to con-
sistently rescue migration by the addition of recombinant human TG2
to the media or by coating the culture vessels with recombinant
human TG2. This could be due to several reasons: insufﬁcient quanti-
ty of TG2 delivered, poor activity of the added TG2, or inappropriate
cellular localization of the added TG2.Our ﬁndings may be exploited in clinical scenarios such as
neurotrophic corneal ulcers in diabetics or persistent corneal epithelial
defects. Epithelial cell adhesion and migration are only one out of the
many processes in corneal wound healing. Processes such as keratocyte
cell death, inﬂammation, and myoﬁbroblast formation are also in-
volved [38,39]. Although TG-2 may potentially be involved in these
other wound healing events [15], our work currently only focused on
the corneal epithelial cell and the role of TG-2 in cell adhesion/
migration.
In summary, the presence of TG-2 enhances wound healing in cor-
neal epithelium through its effects on the phosphorylation of key cell
adhesion proteins. Since serine phosphorylation of paxillin has been
linked to the adhesion of not only epithelial cells but also ﬁbroblasts
[40], and TG-2 affects the adhesion of many cell types [15], serine
phosphorylation of paxillin in a TG-2-dependent manner may be a
conserved signal transduction mechanism for cell adhesion and
cytoskeletal reorganization, and is perhaps activated in all stratiﬁed
epithelium. The exact sequence of signaling events, and the inter-
actions of TG-2 with various extra- or intracellular molecules in this
pathway, remain to be determined, as does the role of TG-2 in
diseases like recurrent corneal erosions, stem cell failure and corneal
epitheliopathy in dry eye and infection.
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